Article
TCR sequencing: applications in immuno-oncology research
3 Feb 2023
Abstract excerpt
Immune checkpoint blockade (ICB)1 and other immunotherapies designed to enhance effective antitumoural T-cell responses2 have revolutionised cancer care, thus placing characterisation of T-cell responses as a central piece in immuno-oncology research. In recent years, T-cell receptor (TCR) sequencing has emerged as a powerful tool to characterise the breadth and depth of T-cell responses. This review will...
Topics
Join the communities discussing this publication.
